跳至主要内容
临床试验/ChiCTR-TRC-11001715
ChiCTR-TRC-11001715已完成4 期

含ω-3 脂肪酸的肠外营养在肝癌行肝切除术后的疗效

国家自然科学基金(NSFC)1 个研究点 分布在 1 个国家目标入组 105 人开始时间: 2010年3月1日最近更新:

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
105
试验地点
1
主要终点
肝功

研究概览

简要总结

研究含ω-3 脂肪酸的肠外营养在肝癌行肝切除术后的疗效及安全性

研究设计

研究类型
干预性研究
主要目的
随机平行对照
盲法
Single

入排标准

年龄范围
18 至 74(—)
性别
All

入选标准

  • Patients performed hepatectomy as a result of liver cancer were enrolled who had malnourished preoperatively according to Subjective Global Assessment(SGA). They were considered malnourished if they met either or both of two criteria:
  • (1) a score of 100 or less on the Nutrition Risk Index(NRI), calculated according to the following formula: 1.519*the serum albumin level(g/L)+0.417*(current weight/usual weight)*100 or
  • (2) any two of the following: a current weight that was 95 percent of the ideal weight or less; a serum albumin level of 35.0g per liter or less; or a serum prealbumin level of 200mg per liter or less.

排除标准

  • were upper gastrointestinal hemorrhage, severe hemorrhagic disorders, explicit acute infectious lesion, overt ascites, Child-Pugh Score C, indocyanine green retention rate at 15min(ICGR15)>30%, serum HBV-DNA>1000K copies/ml and serum alanine aminotransferase>2*ULN, serum triglycerides>2.0mmol/L, circulatory shock, stroke, acute myocardial infarction, renal failure,coma of unknown cause, pregnancy, age of<18 yrs or>75 yrs, and allergic reactions against fish or egg proteins.

研究组 & 干预措施

Group 1

20% Structolipid only

Group 2

20% Structolipid and 10% Omegaven

结局指标

主要结局

肝功

内窥镜

血常规

凝血功能常规

排尿量

生化指标

术中特点

肝切除术类型

postoperative profiles

术后合并症

次要结局

未报告次要终点

研究者

发起方
国家自然科学基金(NSFC)

研究点 (1)

Loading locations...

相似试验